SCHEMBL19089824

SCHEMBL19089824

Clc1ccc(-c2ccc(-c3ccc(C45CC6CC(CC(C6)C4)C5)cc3)cc2)cc1

nearest known ligand 0.57

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
LMNA P02545 5/20 0.57
ALDH1A1 P00352 3/20 0.57
MEN1 O00255 4/20 0.53
KMT2A Q03164 4/20 0.53
SMN1; SMN2 Q16637 2/20 0.53
HTT P42858 1/20 0.53
EPHX2 P34913 3/20 0.47
POLB P06746 1/20 0.47
GAA P10253 1/20 0.47
GFER P55789 1/20 0.47
NPC1 O15118 2/20 0.45
SERPINE1 P05121 1/20 0.45
L3MBTL1 Q9Y468 1/20 0.44
MAPT P10636 1/20 0.42
MAOA P21397 2/20 0.42
MAOB P27338 2/20 0.42
KDM1A O60341 1/20 0.42
RAB9A P51151 2/20 0.41
SPHK2 Q9NRA0 1/20 0.39
KDM4E B2RXH2 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2841371 1.00 LMNA (0.57) LMNAALDH1A1MEN1KMT2ASMN1; SMN2
SCHEMBL18705090 0.94 LMNA (0.63) LMNAALDH1A1MEN1KMT2ASMN1; SMN2
SCHEMBL31463122 0.88 LMNA (0.53) LMNAALDH1A1MEN1KMT2ASMN1; SMN2
SCHEMBL19089827 0.85 LMNA (0.46) LMNAALDH1A1MEN1KMT2ASMN1; SMN2
SCHEMBL24422087 0.84 CYP1A2 (0.43) LMNAALDH1A1MEN1KMT2ASMN1; SMN2
SCHEMBL26360990 0.84 CYP1A2 (0.43) LMNAALDH1A1MEN1KMT2ASMN1; SMN2
SCHEMBL20639562 0.83 LMNA (0.47) LMNAALDH1A1MEN1KMT2ASMN1; SMN2
SCHEMBL2763437 0.82 LMNA (0.77) LMNAALDH1A1MEN1KMT2ASMN1; SMN2
SCHEMBL31005178 0.82 HTT (0.54) LMNAALDH1A1MEN1KMT2ASMN1; SMN2
SCHEMBL19098015 0.82 LMNA (0.59) LMNAALDH1A1MEN1KMT2ASMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10941108-B2 Organic compound and organic electroluminescent element comprising same MATERIAL SCIENCE CO., LTD. 2021-03-09 US disclosed
US-10941108-B2 Organic compound and organic electroluminescent element comprising same MATERIAL SCIENCE CO., LTD. 2021-03-09 US disclosed
US-20190016666-A1 ORGANIC COMPOUND AND ORGANIC ELECTROLUMINESCENT ELEMENT COMPRISING SAME MATERIAL SCIENCE CO., LTD. (KR) 2019-01-17 US disclosed
US-20190016666-A1 ORGANIC COMPOUND AND ORGANIC ELECTROLUMINESCENT ELEMENT COMPRISING SAME MATERIAL SCIENCE CO., LTD. (KR) 2019-01-17 US disclosed
WO-2017116168-A1 ORGANIC ELECTROLUMINESCENT ELEMENT 머티어리얼사이언스 주식회사 2017-07-06 WO disclosed
WO-2017116167-A1 ORGANIC COMPOUND AND ORGANIC ELECTROLUMINESCENT ELEMENT COMPRISING SAME 머티어리얼사이언스 주식회사 2017-07-06 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10941108-B2 Organic compound and organic electroluminescent element comprising same OCIAD2, OR51E2, OCIAD1 LMNA 2950/4885ALDH1A1 277/4885MEN1 3245/4885
US-20190016666-A1 ORGANIC COMPOUND AND ORGANIC ELECTROLUMINESCENT ELEMENT COMPRISING SAME OCIAD2, OR51E2, OCIAD1 LMNA 2950/4885ALDH1A1 277/4885MEN1 3245/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.